StockData
Quantum Biopharma Ltd. logo

Quantum Biopharma Ltd. (QNTM) stock

QNTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026Score 1/30
$1.59+0.15 (+10.42%)

Close on Nov 17, 2026Market cap $6.18MP/E –Yield –

Quantum Biopharma ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Quantum Biopharma's ebitda for the twelve months ending Jun 30, 2026 was -$11.78M. For fiscal 2025 it was -$14.76M. The highest annual figure on record is -$14.76M in fiscal 2025.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$14.76M–
FY2024Dec 31, 2024-$15.65M–
FY2023Dec 31, 2023-$21.28M–
FY2022Dec 31, 2022-$22.90M–
FY2021Dec 31, 2021-$29.70M–
FY2020Dec 31, 2020-$26.79M–
FY2019Dec 31, 2019-$20.54M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.17M–
Q1 FY2026Mar 31, 2026-$2.84M–
Q4 FY2025Dec 31, 2025-$2.24M–
Q3 FY2025Sep 30, 2025-$4.53M–
Q2 FY2025Jun 30, 2025-$4.71M–
Q1 FY2025Mar 31, 2025-$3.27M–
Q4 FY2024Dec 31, 2024-$6.13M–
Q3 FY2024Sep 30, 2024-$4.06M–
Q2 FY2024Jun 30, 2024-$3.32M–
Q1 FY2024Mar 31, 2024-$2.14M–
Q4 FY2023Dec 31, 2023-$1.68M–
Q3 FY2023Sep 30, 2023-$3.17M–

More Quantum Biopharma figures

See a number that looks wrong?